These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Delaware
|
36-3922969
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
7720 N. Lehigh Avenue, Niles, Illinois
|
60714
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Item
|
|
Page
|
|
|
|
|
|
Part I
|
|
|
|
|
|
|
|
1.
|
|
|
|
|
Consolidated Statements of Operations for the Three and Nine Months Ended October 31, 2015 and 2014
|
|
|
|
Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended October 31, 2015 and 2014
|
2
|
|
|
Consolidated Balance Sheets as of
October 31, 2015 and January 31, 2015
|
|
|
|
Consolidated Statements of Stockholders' Equity as of October 31, 2015 and January 31, 2015
|
|
|
|
Consolidated Statements of Cash Flows for the Nine Months Ended October
31, 2015 and 2014
|
|
|
|
||
|
|
|
|
|
2.
|
||
|
|
|
|
|
4.
|
||
|
|
|
|
|
Part II
|
|
|
|
6.
|
18
|
|
|
|
|
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
|
2015
|
|
2014
|
|
||||
|
Net sales
|
|
$66,316
|
|
|
$43,819
|
|
|
|
$144,051
|
|
|
$156,713
|
|
|
Cost of sales
|
49,345
|
|
37,098
|
|
|
117,379
|
|
123,458
|
|
||||
|
Gross profit
|
16,971
|
|
6,721
|
|
|
26,672
|
|
33,255
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating expenses
|
|
|
|
|
|
||||||||
|
General and administrative expenses
|
6,775
|
|
5,291
|
|
|
18,100
|
19,421
|
|
|||||
|
Selling expenses
|
2,836
|
|
2,666
|
|
|
8,487
|
7,566
|
|
|||||
|
Total operating expenses
|
9,611
|
|
7,957
|
|
|
26,587
|
|
26,987
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income (loss) from operations
|
7,360
|
|
(1,236
|
)
|
|
85
|
|
6,268
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income from joint venture
|
408
|
|
903
|
|
|
524
|
|
1,114
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Interest expense, net
|
211
|
|
293
|
|
|
457
|
|
793
|
|
||||
|
Income (loss) from continuing operations before income taxes
|
7,557
|
|
(626
|
)
|
|
152
|
|
6,589
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income tax expense
|
1,443
|
|
11
|
|
|
1,084
|
|
1,553
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income (loss) from continuing operations
|
6,114
|
|
(637
|
)
|
|
(932
|
)
|
5,036
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income (loss) from discontinued operations, net of tax
|
—
|
|
265
|
|
|
—
|
|
(217
|
)
|
||||
|
|
|
|
|
|
|
||||||||
|
Net income (loss)
|
|
$6,114
|
|
|
($372
|
)
|
|
|
($932
|
)
|
$4,819
|
||
|
|
|
|
|
|
|
||||||||
|
Weighted average common shares outstanding
|
|
|
|
|
|
||||||||
|
Basic
|
7,290
|
|
7,290
|
|
|
7,273
|
|
7,238
|
|
||||
|
Diluted
|
7,367
|
|
7,290
|
|
|
7,273
|
|
7,337
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Earnings (loss) per share from continuing operations
|
|
|
|
|
|
||||||||
|
Basic
|
|
$0.84
|
|
|
($0.09
|
)
|
|
($0.13)
|
$0.70
|
||||
|
Diluted
|
|
$0.83
|
|
|
($0.09
|
)
|
|
($0.13)
|
$0.69
|
||||
|
Earnings (loss) per share from discontinued operations
|
|
|
|
|
|
||||||||
|
Basic and diluted
|
|
$—
|
|
|
$0.04
|
|
|
|
$—
|
|
|
($0.03
|
)
|
|
Earnings (loss) per share
|
|
|
|
|
|
||||||||
|
Basic
|
$0.84
|
|
($0.05
|
)
|
|
|
($0.13
|
)
|
|
$0.67
|
|
||
|
Diluted
|
$0.83
|
|
($0.05
|
)
|
|
($0.13)
|
|
$0.66
|
|
||||
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
|
2015
|
|
2014
|
|
||||
|
Net income (loss)
|
|
$6,114
|
|
|
($372
|
)
|
|
|
($932
|
)
|
|
$4,819
|
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive (loss) income
|
|
|
|
|
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
(148
|
)
|
(484
|
)
|
|
10
|
|
(654
|
)
|
||||
|
Interest rate swap, net of tax
|
(1
|
)
|
(8
|
)
|
|
14
|
|
(30
|
)
|
||||
|
Minimum pension liability adjustment, net of tax
|
196
|
|
—
|
|
|
196
|
|
—
|
|
||||
|
Other comprehensive income (loss)
|
47
|
|
(492
|
)
|
|
220
|
|
(684
|
)
|
||||
|
|
|
|
|
|
|
||||||||
|
Comprehensive income (loss)
|
|
$6,161
|
|
|
($864
|
)
|
|
|
($712
|
)
|
|
$4,135
|
|
|
(In thousands except per share data)
|
October 31, 2015
|
|
January 31, 2015
|
|
||
|
ASSETS
|
Unaudited
|
|
|
|||
|
Current assets
|
|
|
||||
|
Cash and cash equivalents
|
|
$10,882
|
|
|
$10,508
|
|
|
Restricted cash
|
433
|
|
428
|
|
||
|
Trade accounts receivable, less allowance for doubtful accounts of $585 at October 31, 2015 and $110 at January 31, 2015
|
58,967
|
|
41,847
|
|
||
|
Inventories, net
|
35,378
|
|
29,770
|
|
||
|
Assets held for sale
|
3,136
|
|
—
|
|
||
|
Prepaid expenses and other current assets
|
2,955
|
|
4,349
|
|
||
|
Costs and estimated earnings in excess of billings on uncompleted contracts
|
2,814
|
|
700
|
|
||
|
Total current assets
|
114,565
|
|
87,602
|
|
||
|
Property, plant and equipment, net of accumulated depreciation
|
39,954
|
|
41,486
|
|
||
|
Other assets
|
|
|
||||
|
Note receivable from joint venture
|
2,036
|
|
3,931
|
|
||
|
Investment in joint venture
|
9,034
|
|
8,514
|
|
||
|
Cash surrender value on life insurance policies, net
|
3,258
|
|
3,256
|
|
||
|
Other assets
|
3,486
|
|
3,215
|
|
||
|
Assets held for sale long-term
|
441
|
|
534
|
|
||
|
Total other assets
|
18,255
|
|
19,450
|
|
||
|
Total assets
|
|
$172,774
|
|
|
$148,538
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
||||
|
Current liabilities
|
|
|
||||
|
Trade accounts payable
|
|
$22,125
|
|
|
$11,072
|
|
|
Accrued compensation and payroll taxes
|
12,146
|
|
5,551
|
|
||
|
Commissions and management incentives payable
|
4,804
|
|
5,734
|
|
||
|
Revolving line domestic
|
18,735
|
|
11,353
|
|
||
|
Current maturities of long-term debt
|
16,314
|
|
5,679
|
|
||
|
Customers' deposits
|
6,017
|
|
7,341
|
|
||
|
Billings in excess of costs and estimated earnings on uncompleted contracts
|
2,207
|
|
681
|
|
||
|
Other accrued liabilities
|
2,154
|
|
2,486
|
|
||
|
Deferred tax liabilities - current
|
167
|
|
165
|
|
||
|
Income taxes payable
|
1,550
|
|
1,688
|
|
||
|
Total current liabilities
|
86,219
|
|
51,750
|
|
||
|
Long-term liabilities
|
|
|
||||
|
Long-term debt, less current maturities
|
8,930
|
|
12,603
|
|
||
|
Deferred compensation liabilities
|
436
|
|
6,560
|
|
||
|
Deferred tax liabilities - long-term
|
752
|
|
309
|
|
||
|
Other long-term liabilities
|
3,794
|
|
3,793
|
|
||
|
Total long-term liabilities
|
13,912
|
|
23,265
|
|
||
|
Stockholders' equity
|
|
|
||||
|
Common stock, $.01 par value, authorized 50,000 shares; 7,288 issued and outstanding at October 31, 2015 and 7,291 issued and outstanding at January 31, 2015
|
73
|
|
73
|
|
||
|
Additional paid-in capital
|
52,777
|
|
52,655
|
|
||
|
Treasury Stock 45 shares at October 31, 2015 and none at January 31, 2015
|
(290
|
)
|
—
|
|
||
|
Retained earnings
|
24,392
|
|
25,324
|
|
||
|
Accumulated other comprehensive loss
|
(4,309
|
)
|
(4,529
|
)
|
||
|
Total stockholders' equity
|
72,643
|
|
73,523
|
|
||
|
Total liabilities and stockholders' equity
|
|
$172,774
|
|
|
$148,538
|
|
|
($ in thousands, except share data)
|
|
Additional Paid-in Capital
|
Retained Earnings
|
Treasury Stock
|
Accumulated Other Comprehensive Income (Loss)
|
Total Stockholders' Equity
|
||||||||
|
Common Stock
|
||||||||||||||
|
Total stockholders' equity at January 31, 2015
|
$73
|
$52,655
|
$25,324
|
|
$—
|
|
($4,529)
|
$73,523
|
||||||
|
|
|
|
|
|
|
|
||||||||
|
Net loss
|
|
|
|
($932
|
)
|
|
|
(932
|
)
|
|||||
|
Restricted shares vested and payroll taxes paid with shares
|
—
|
|
(15
|
)
|
|
|
|
(15
|
)
|
|||||
|
Repurchase of common stock
|
|
|
|
(290
|
)
|
|
(290
|
)
|
||||||
|
Stock-based compensation expense
|
|
137
|
|
|
|
|
137
|
|
||||||
|
Interest rate swap
|
|
|
|
|
26
|
|
26
|
|
||||||
|
Pension liability adjustment
|
|
|
|
|
333
|
|
333
|
|
||||||
|
Foreign currency translation adjustments
|
|
|
|
|
(45
|
)
|
(45
|
)
|
||||||
|
Tax benefit/expense on above items
|
|
|
|
|
(94
|
)
|
(94
|
)
|
||||||
|
Total stockholders' equity at October 31, 2015
|
$73
|
$52,777
|
$24,392
|
($290)
|
($4,309)
|
$72,643
|
||||||||
|
Shares
|
2015
|
|
2014
|
|
|
|
Balances at beginning of year
|
7,290,576
|
|
7,168,537
|
|
|
|
Shares issued (repurchased)
|
(2,151
|
)
|
122,039
|
|
|
|
Balances at period end
|
7,288,425
|
|
7,290,576
|
|
|
|
(In thousands)
|
Nine Months Ended October 31,
|
|||||
|
|
2015
|
|
2014
|
|
||
|
Operating activities
|
|
|
||||
|
Net (loss) income
|
|
($932
|
)
|
|
$4,819
|
|
|
Adjustments to reconcile net (loss) income to net cash flows (used in) provided by operating activities
|
|
|
||||
|
Depreciation and amortization
|
4,425
|
|
4,299
|
|
||
|
Loss on disposal of discontinued operations
|
—
|
|
283
|
|
||
|
Deferred tax expense
|
479
|
|
420
|
|
||
|
Stock-based compensation expense (benefit)
|
137
|
|
(57
|
)
|
||
|
Income from joint venture
|
(524
|
)
|
(1,114
|
)
|
||
|
Cash surrender value on life insurance policies
|
(2
|
)
|
(153
|
)
|
||
|
Gain on disposal of fixed assets
|
1
|
|
4
|
|
||
|
Provision on uncollectible accounts
|
476
|
|
(592
|
)
|
||
|
Changes in operating assets and liabilities
|
|
|
||||
|
Accounts receivable
|
(17,820
|
)
|
5,108
|
|
||
|
Inventories
|
(5,687
|
)
|
2,434
|
|
||
|
Costs and estimated earnings in excess of billings on uncompleted contracts
|
(589
|
)
|
(2,598
|
)
|
||
|
Accounts payable
|
11,206
|
|
(4,494
|
)
|
||
|
Accrued compensation and payroll taxes
|
5,686
|
|
(3,309
|
)
|
||
|
Customers' deposits
|
(1,326
|
)
|
416
|
|
||
|
Income taxes receivable and payable
|
(98
|
)
|
(1,311
|
)
|
||
|
Prepaid expenses and other current assets
|
1,356
|
|
805
|
|
||
|
Other assets and liabilities
|
(6,575
|
)
|
107
|
|
||
|
Net cash (used in) provided by operating activities
|
(9,787
|
)
|
5,067
|
|
||
|
Investing activities
|
|
|
||||
|
Capital expenditures
|
(5,971
|
)
|
(4,208
|
)
|
||
|
Payments on loan from joint venture
|
1,890
|
|
—
|
|
||
|
Proceeds from sales of property and equipment
|
—
|
|
8
|
|
||
|
Net cash used in investing activities
|
(4,081
|
)
|
(4,200
|
)
|
||
|
Financing activities
|
|
|
||||
|
Proceeds from revolving lines
|
79,175
|
|
61,366
|
|
||
|
Proceeds from debt
|
783
|
|
1,510
|
|
||
|
Proceeds from borrowing against life insurance policies
|
1,916
|
|
—
|
|
||
|
Payments of debt on revolving lines of credit
|
(63,177
|
)
|
(61,053
|
)
|
||
|
Payments of other debt
|
(1,699
|
)
|
(2,059
|
)
|
||
|
Payments of borrowing against life insurance policies
|
(1,916
|
)
|
—
|
|
||
|
(Decrease) increase in drafts payable
|
(122
|
)
|
722
|
|
||
|
Payments on capitalized lease obligations
|
(659
|
)
|
(573
|
)
|
||
|
Payments for repurchase of common stock
|
(290
|
)
|
—
|
|
||
|
Stock options exercised and restricted shares issued
|
(15
|
)
|
388
|
|
||
|
Net cash provided by financing activities
|
13,996
|
|
301
|
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
246
|
|
(147
|
)
|
||
|
Net increase in cash and cash equivalents
|
374
|
|
1,021
|
|
||
|
Cash and cash equivalents - beginning of period
|
10,508
|
|
13,395
|
|
||
|
Cash and cash equivalents - end of period
|
|
$10,882
|
|
|
$14,416
|
|
|
Supplemental cash flow information
|
|
|
||||
|
Interest paid
|
|
$836
|
|
|
$1,165
|
|
|
Income taxes paid
|
849
|
|
2,503
|
|
||
|
Fixed assets acquired under capital leases
|
1,215
|
|
614
|
|
||
|
Funds held in escrow related to the sale of Thermal Care, Inc. assets
|
—
|
|
61
|
|
||
|
1.
|
Basis of presentation.
The interim consolidated financial statements of MFRI, Inc. and subsidiaries ("MFRI," "Company," or "Registrant") are unaudited, but include all adjustments which the Company's management considers necessary to present fairly the financial position and results of operations for the periods presented. These adjustments consist of normal recurring adjustments. Information and footnote disclosures have been omitted pursuant to Securities and Exchange Commission ("SEC") rules and regulations. The consolidated balance sheet as of
January 31, 2015
is derived from the audited consolidated balance sheet as of that date. The results of operations for any interim period are not necessarily indicative of future or annual results. Interim financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's latest Annual Report on Form 10-K. The Company's fiscal year ends on January 31. Years and balances described as
2015
and
2014
are for the
nine months ended October 31,
2015
and
2014
, respectively.
|
|
2.
|
Business segment reporting.
The Company has
two
reportable segments:
Piping Systems, which engineers, designs, manufactures and sells specialty piping, leak detection and location systems
, and
Filtration Products, which manufactures custom-designed industrial filtration products to remove particulates from air and other gas streams
.
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
|
2015
|
|
2014
|
|
||||
|
Net sales
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$46,950
|
|
|
$26,540
|
|
|
|
$92,374
|
|
|
$102,683
|
|
|
Filtration Products
|
19,366
|
|
17,279
|
|
|
51,677
|
|
54,030
|
|
||||
|
Total
|
|
$66,316
|
|
|
$43,819
|
|
|
|
$144,051
|
|
|
$156,713
|
|
|
Gross profit
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$14,315
|
|
|
$4,609
|
|
|
|
$19,796
|
|
|
$25,913
|
|
|
Filtration Products
|
2,656
|
|
2,112
|
|
|
6,876
|
|
7,342
|
|
||||
|
Total
|
|
$16,971
|
|
|
$6,721
|
|
|
|
$26,672
|
|
|
$33,255
|
|
|
Income (loss) from operations
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$9,721
|
|
|
$1,096
|
|
|
|
$7,470
|
|
|
$12,896
|
|
|
Filtration Products
|
(162
|
)
|
(726
|
)
|
|
(1,337
|
)
|
(1,300
|
)
|
||||
|
Corporate
|
(2,199
|
)
|
(1,606
|
)
|
|
(6,048
|
)
|
(5,328
|
)
|
||||
|
Total
|
|
$7,360
|
|
|
($1,236
|
)
|
|
|
$85
|
|
|
$6,268
|
|
|
3.
|
Income taxes.
The determination of the consolidated provision for income taxes, deferred tax assets and liabilities and related valuation allowances requires management to make judgments and estimates. As a company with subsidiaries in foreign jurisdictions, the process of calculating income taxes involves estimating current tax obligations and exposures in each jurisdiction as well as making judgments regarding the future recoverability of deferred tax assets. Income earned in the United Arab Emirates ("U.A.E.") is not subject to local country income tax. Additionally, the relative proportion of taxable income earned domestically versus internationally can fluctuate significantly from period to period. Changes in the estimated level of annual pre-tax income, tax laws and the results of tax audits can affect the overall effective income tax rate, which impacts the level of income tax expense and net income. Judgments and estimates related to the Company's projections and assumptions are inherently uncertain; therefore, actual results could differ materially from projections.
|
|
4.
|
Impairment of long-lived assets and assets held for sale.
The Company evaluates long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. There was no impairment of long-lived assets as of October 31, 2015 and January 31, 2015.
|
|
5.
|
Other intangible assets with definite lives.
The Company owns several patents, including those covering features of its piping and electronic leak detection systems.
Patents are capitalized and amortized on a straight-line basis over a period not to exceed the legal lives of the patents.
The Company expenses costs incurred to renew or extend the term of intangible assets
. Gross patents were
$2.73 million
and
$2.68 million
as of
October 31, 2015
and
January 31, 2015
, respectively. Accumulated amortization was approximately
$2.32 million
and
$2.28 million
as of
October 31, 2015
and
January 31, 2015
, respectively. Future amortizations over the next five years ending January 31 will be
$13,950
in
2016
,
$51,950
in
2017
,
$48,900
in
2018
,
$39,950
in
2019
,
$36,950
in
2020
, and
$214,700
thereafter. Patents are included in other assets in the balance sheet.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
||||
|
Patent amortization expense
|
|
$14
|
|
|
$13
|
|
|
$40
|
|
|
$38
|
|
|
6.
|
Investment in joint venture.
In
October 2009
, the Company invested
$5.9 million
, which consisted of
$2 million
for a
49%
interest and
$3.9 million
for a note receivable, in a Canadian joint venture with The Bayou Companies, Inc., a subsidiary of Aegion Corporation. The joint venture operates in Camrose, Alberta, Canada, which provides the Company the opportunity to participate in the oil sands market. During the first six months of 2015, the Company received
$1.9 million
in principal repayments on the note receivable.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
||||
|
Share of income from joint venture
|
|
$408
|
|
|
$903
|
|
|
$524
|
|
|
$1,114
|
|
|
|
October 31, 2015
|
|
January 31, 2015
|
|
|
Current assets
|
$11,008
|
$13,820
|
||
|
Noncurrent assets
|
13,366
|
|
14,023
|
|
|
Current liabilities
|
5,127
|
|
4,499
|
|
|
Noncurrent liabilities
|
4,220
|
|
9,013
|
|
|
Equity
|
15,027
|
|
14,331
|
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
||||
|
Revenue
|
|
$8,780
|
|
|
$11,886
|
|
|
$18,922
|
|
|
$28,666
|
|
|
Gross profit
|
1,603
|
|
3,310
|
|
3,082
|
|
5,426
|
|
||||
|
Income from continuing operations
|
1,257
|
|
2,749
|
|
1,823
|
|
3,820
|
|
||||
|
Net income
|
833
|
|
1,843
|
|
1,070
|
|
2,274
|
|
||||
|
7.
|
Stock-based
compensation.
The Company has stock-based compensation awards that can be granted to eligible employees, officers or directors.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
||||
|
Stock-based compensation expense (benefit)
|
|
$87
|
|
|
$74
|
|
|
$50
|
|
|
($217
|
)
|
|
Restricted stock based compensation expense
|
|
$79
|
|
|
$142
|
|
|
$337
|
|
|
$122
|
|
|
|
Nine Months Ended October 31,
|
|
|
Fair value assumptions
|
2015
|
2014
|
|
Expected volatility
|
40.88% - 59.39%
|
40.88% - 59.39%
|
|
Risk free interest rate
|
.74% - 1.77%
|
.74% - 1.77%
|
|
Dividend yield
|
none
|
none
|
|
Expected life
|
4.9 - 5.1 years
|
4.9 - 5.1 years
|
|
Option activity
|
Options
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Term
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2015
|
764
|
|
|
$11.45
|
|
5.7
|
|
$—
|
|
|
Granted
|
51
|
|
6.38
|
|
|
|
|||
|
Expired or forfeited
|
(62
|
)
|
10.11
|
|
|
|
|||
|
Outstanding end of period
|
753
|
|
11.22
|
|
5.4
|
1
|
|
||
|
|
|
|
|
|
|||||
|
Exercisable end of period
|
567
|
|
|
$11.81
|
|
4.4
|
|
$—
|
|
|
Unvested option activity
|
Options
|
Weighted Average Grant Date Fair Value
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2015
|
232
|
|
|
$10.11
|
|
|
$—
|
|
|
Granted
|
51
|
|
6.38
|
|
|
|||
|
Vested
|
(87
|
)
|
|
|
||||
|
Expired or forfeited
|
(10
|
)
|
10.55
|
|
|
|||
|
Outstanding end of period
|
186
|
|
|
$9.40
|
|
|
$—
|
|
|
Restricted stock activity
|
Restricted Shares
|
Weighted Average Grant Price Per Share
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2015
|
33
|
|
|
$11.53
|
|
|
$186
|
|
|
Granted
|
92
|
|
6.38
|
|
|
|||
|
Issued
|
(48
|
)
|
|
|
||||
|
Outstanding end of period
|
77
|
|
|
$8.60
|
|
|
$436
|
|
|
8.
|
Treasury stock / share repurchase program.
On
February 5, 2015
, the Company's Board of Directors approved a share repurchase program, which authorizes the Company to use up to
$2 million
for the purchase of its outstanding shares of common stock. Share repurchases may be executed through open market or privately negotiated transactions on or prior to
December 31, 2015
.
|
|
Period
|
Total number of shares purchased (in thousands)
|
Average price paid per share
|
|
February
|
28
|
$6.64
|
|
March
|
17
|
6.27
|
|
April to October
|
—
|
—
|
|
9.
|
Earnings per share.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
|
Basic weighted average common shares outstanding
|
7,290
|
|
7,290
|
|
7,273
|
|
7,238
|
|
|
Dilutive effect of equity compensation plans
|
77
|
|
—
|
|
—
|
|
99
|
|
|
Weighted average common shares outstanding assuming full dilution
|
7,367
|
|
7,290
|
|
7,273
|
|
7,337
|
|
|
|
|
|
|
|
||||
|
Stock options not included in the computation of diluted earnings per share of common stock because the option exercise prices exceeded the average market prices of the common shares
|
753
|
|
346
|
|
743
|
|
257
|
|
|
|
|
|
|
|
||||
|
Stock options with an exercise price below the average market price
|
—
|
|
421
|
|
10
|
|
510
|
|
|
10.
|
Interest expense, net.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
||||
|
Interest expense
|
|
$335
|
|
|
$432
|
|
|
$872
|
|
|
$1,175
|
|
|
Interest income
|
(124
|
)
|
(139
|
)
|
(415
|
)
|
(382
|
)
|
||||
|
Interest expense, net
|
|
$211
|
|
|
$293
|
|
|
$457
|
|
|
$793
|
|
|
11.
|
|
|
12
.
|
Fair value of financial instruments.
At
October 31, 2015
, an interest rate swap agreement that relates to a mortgage note in Denmark was in effect with a notional value of
$1.3 million
that matures
December 2021
. The Company entered into this interest swap agreement in 2012 to reduce its exposure to market risks from changing interest rates and exchange the variable rate to fixed interest rate payments of
2.47%
. The exchange traded swap is valued on a recurring basis using quoted market prices and was classified within Level 2 of the fair value hierarchy, which includes significant other observable inputs because the exchange is not deemed an active market. The swap agreement is a cash flow hedge. The derivative mark to market was
$0.1 million
at both
October 31, 2015
and
January 31, 2015
. This was included in other long-term liabilities on the consolidated balance sheets.
|
|
13.
|
Recent accounting pronouncements
.
In November 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) 2015-17, Balance Sheet Classification of Deferred Taxes. The ASU requires entities to classify deferred tax liabilities and assets as noncurrent in a classified statement of financial position. This ASU is effective for fiscal years beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted for all entities as of the beginning of an interim or annual reporting period. The adoption of this guidance by the Company is not expected to have a material impact on the Company's consolidated financial statements.
|
|
14.
|
Reclassifications.
Reclassifications were made to the prior-year statement of cashflow to conform to the current-year presentations.
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
|||||||||||||||||
|
($ in thousands)
|
2015
|
|
%
|
2014
|
|
%
|
% Increase
|
|
2015
|
|
%
|
|
2014
|
%
|
|
% Decrease
|
||||
|
Net sales
|
$46,950
|
|
$26,540
|
|
77
|
%
|
|
$92,374
|
|
$102,683
|
|
(10
|
)%
|
|||||||
|
Gross profit
|
14,315
|
|
30
|
%
|
4,609
|
|
17
|
%
|
211
|
%
|
|
19,796
|
21
|
%
|
25,913
|
25
|
%
|
(24
|
)%
|
|
|
Income from operations
|
9,721
|
|
21
|
%
|
1,096
|
|
4
|
%
|
787
|
%
|
|
7,470
|
|
8
|
%
|
12,896
|
13
|
%
|
(42
|
)%
|
|
Income from joint venture
|
408
|
|
|
903
|
|
|
|
|
524
|
|
1,114
|
|
|
|||||||
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||||||
|
($ in thousands)
|
2015
|
|
%
|
2014
|
|
%
|
% Increase
|
|
2015
|
|
%
|
|
2014
|
|
%
|
|
% Decrease
|
|
Net sales
|
$19,366
|
|
$17,279
|
|
12%
|
|
$51,677
|
|
$54,030
|
|
(4)%
|
||||||
|
Gross profit
|
2,656
|
|
14%
|
2,112
|
|
12%
|
26%
|
|
6,876
|
13.3
|
%
|
7,342
|
13.6
|
%
|
(6)%
|
||
|
Loss from operations
|
(162
|
)
|
(1)%
|
(726
|
)
|
(4)%
|
78%
|
|
(1,337
|
)
|
(3
|
)%
|
(1,300
|
)
|
(2
|
)%
|
(3)%
|
|
31
|
|
Rule 13a - 14(a)/15d - 14(a) Certifications
(1) Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
(2) Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32
|
|
Section 1350 Certifications (Chief Executive Officer and Chief Financial Officer certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
|
|
101.INS
|
|
XBRL Instance
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation
|
|
Date:
|
December 8, 2015
|
/s/ Bradley E. Mautner
|
|
|
|
Bradley E. Mautner
|
|
|
|
Director, President and
|
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
Date:
|
December 8, 2015
|
/s/ Karl J. Schmidt
|
|
|
|
Karl J. Schmidt
|
|
|
|
Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|